BackSangamo Therapeutics Overview

Sangamo Therapeutics Net Income

Profitability analysis for SGMO.

Quarterly Net Income

-$31.00M
↓ 1.3% YoY

As of Mar 2026

Annual Net Income (TTM)

-$123.33M
↓ 55.23% YoY

Trailing 12 months ending Mar 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin